RESUMEN
Locally-advanced periocular basal cell carcinoma (BCC) pose many therapeutic challenges due to the need to preserve functionality and cosmesis of the orbit and periocular area. Surgical excision and subsequent orbital exenteration are two recognized modalities of treatment. Vismodegib is currently an FDA-approved monotherapy for locally-advanced and metastatic BCC. We present a case of the use of vismodegib as neoadjuvant therapy prior to surgical excision of a locally-advanced periocular recurrent BCC in a 75-year-old male. The patient’s tumor successfully responded to vismodegib allowing surgical excision with clear margins. The orbit was saved in a patient who otherwise would have required complete orbital exenteration. J Drugs Dermatol. 20(5):552-554. doi:10.36849/JDD.5661.
Asunto(s)
Anilidas/administración & dosificación , Carcinoma Basocelular/terapia , Neoplasias de los Párpados/terapia , Recurrencia Local de Neoplasia/terapia , Piridinas/administración & dosificación , Neoplasias Cutáneas/terapia , Administración Oral , Anciano , Anilidas/efectos adversos , Carcinoma Basocelular/diagnóstico , Carcinoma Basocelular/patología , Neoplasias de los Párpados/diagnóstico , Neoplasias de los Párpados/patología , Párpados/diagnóstico por imagen , Párpados/patología , Párpados/cirugía , Humanos , Imagen por Resonancia Magnética , Masculino , Márgenes de Escisión , Terapia Neoadyuvante/métodos , Recurrencia Local de Neoplasia/diagnóstico , Recurrencia Local de Neoplasia/patología , Tratamientos Conservadores del Órgano/métodos , Piridinas/efectos adversos , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/patología , Resultado del TratamientoRESUMEN
BACKGROUND: Actinic Keratosis is an intraepidermal neoplasm that represents the second most common reason for dermatologic visits in the United States. Sustained clearance with existing therapies is highly variable. OBJECTIVE: To assess the effects of combination and monotherapy with photodynamic therapy (PDT), grenz ray therapy, and PDT with microneedling (microchannel skin system) for actinic damage of the dorsal forearms and hands. METHODS: Full ethics approval was obtained through a Human Subjects Committee. Four patients with diffuse actinic field damage on their forearms and hands were recruited for the study. The dorsal forearm and hand from the elbow to the metacarpophalangeal joint were divided into four equal sections. Section 1 was treated with PDT. Section 2 was treated with grenz ray. Section 3 was treated with PDT plus microneedling. Section 4 was treated with grenz ray and PDT with microneedling. Lesion counts were recorded with transparent grids, photographed and evaluated by the same investigator at baseline, 1, 2, 3 and 6 months. RESULTS: At month 6 post treatment, lesion counts, as a per cent reduction from baseline, were 91.7% in section 1 (PDT); 97.3% in section 2 (grenz ray); 92.9% in section 3 (PDT + microneedle); and 93.9% in section 4 (grenz ray + PDT + microneedle). CONCLUSION: The greatest reduction occurred in the grenz ray monotherapy section and the second greatest reduction in the grenz ray, PDT, microneedling section. Further research on the efficacy of grenz ray therapy for field treatment of actinic keratosis of the forearms and hands is needed.
Asunto(s)
Queratosis Actínica/terapia , Fotoquimioterapia , Terapia por Rayos X , Anciano , Anciano de 80 o más Años , Punción Seca , Femenino , Antebrazo , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Polycrystalline ZnSe is an exciting source of broadband supercontinuum and high-harmonic generation via random quasi phase matching, exhibiting broad transparency in the mid-infrared (0.5-20 µm). In this work, the effects of wavelength, pulse power, intensity, propagation length, and crystallinity on supercontinuum and high harmonic generation are investigated experimentally using ultrafast mid-infrared pulses. Observed harmonic conversion efficiency scales linearly in propagation length, reaching as high as 36%. For the first time to our knowledge, n2 is measured for mid-infrared wavelengths in ZnSe: n2(λ=3.9 µm)=(1.2±0.3)×10-14 cm2/W. Measured n2 is applied to simulations modeling high-harmonic generation in polycrystalline ZnSe as an effective medium.
RESUMEN
Pyoderma gangrenosum (PG) is a destructive ulcerative process, which is usually idiopathic or associated with underlying systemic disease. Its pathogenesis remains unknown. A 30-year-old male with a history of Crohn's disease presented with an advanced perineal and inguinal ulcer consistent with pyoderma gangrenosum, which only partially responded to oral and intralesional corticosteroids and adalimumab 80mg biweekly. The patient was started on adjunct combination cyclosporine and thalidomide, which resulted in prompt relief and profound healing. Treatment of pyoderma gangrenosum is often challenging with no standardized treatment protocols. Combination therapy should be considered in patients with refractory disease, especially with failure of monotherapy. J Drugs Dermatol. 2019;18(3):307-310.
Asunto(s)
Enfermedad de Crohn/complicaciones , Ciclosporina/administración & dosificación , Inmunosupresores/administración & dosificación , Piodermia Gangrenosa/tratamiento farmacológico , Talidomida/administración & dosificación , Adalimumab/administración & dosificación , Corticoesteroides/administración & dosificación , Adulto , Antiinflamatorios/administración & dosificación , Diagnóstico Diferencial , Quimioterapia Combinada , Humanos , Masculino , Perineo , Piodermia Gangrenosa/diagnóstico , Piodermia Gangrenosa/patologíaRESUMEN
Recalcitrant cutaneous sarcoidosis with perianal involvement is rare. To our knowledge we present the first documented case of cutaneous sarcoidosis with perianal involvement successfully treated with adalimumab.
J Drugs Dermatol. 2017;16(12):1305-1306.
.Asunto(s)
Adalimumab/uso terapéutico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Sarcoidosis/diagnóstico , Adalimumab/administración & dosificación , Canal Anal/patología , Anticuerpos Monoclonales Humanizados/administración & dosificación , Diagnóstico Diferencial , Humanos , Inyecciones Subcutáneas , Masculino , Persona de Mediana Edad , Sarcoidosis/tratamiento farmacológico , Sarcoidosis/patología , Resultado del TratamientoRESUMEN
Agent Blue was an arsenical herbicide used extensively in the Vietnam War. Arsenic is one of the known causes of acquired palmoplantar keratoderma (PPK). The most common manifestation of arsenic exposure in susceptible individuals is bilateral palmoplantar hyperkeratosis. We report a 67-year-old man with no known prior exposure to arsenic in the USA or family history of PPK who developed multiple squamous cell carcinoma in situ (SCCIS) and palmoplantar hyperkeratotic lesions beginning 23 years after service in Vietnam. The SCCIS were located on the trunk and extremities in both sun-exposed and non-sun-exposed sites and his palmoplantar lesions were diagnosed concurrently with his SCCIS. He has continued to develop SCCIS since his first visit to our clinic 25 years ago.
Asunto(s)
Enfermedad de Bowen/inducido químicamente , Herbicidas/toxicidad , Queratodermia Palmoplantar/inducido químicamente , Neoplasias Cutáneas/inducido químicamente , Anciano , Humanos , Masculino , Veteranos , Guerra de VietnamAsunto(s)
Carcinoma de Células Escamosas/inducido químicamente , Carcinoma de Células Escamosas/cirugía , Diuréticos/efectos adversos , Hidroclorotiazida/efectos adversos , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/cirugía , Anciano , Estudios Transversales , Femenino , Florida , Humanos , Masculino , Cirugía de Mohs , RiesgoAsunto(s)
Agua Potable/parasitología , Esparganosis/patología , Plerocercoide/aislamiento & purificación , Anciano , Albendazol/uso terapéutico , Animales , Antihelmínticos/uso terapéutico , Antinematodos/uso terapéutico , Parasitología de Alimentos , Humanos , Mebendazol/uso terapéutico , Microscopía Fluorescente , Praziquantel/uso terapéutico , Esparganosis/tratamiento farmacológico , Esparganosis/cirugía , Tórax , Resultado del TratamientoRESUMEN
Multiple basal cell carcinomas (BCC) are a significant cause of morbidity and disfigurement in patients with naevoid basal cell carcinoma syndrome (NBCCS). Chemopreventive strategies are needed to reduce the formation of new BCC in these patients. Appropriate evidence-based guidelines for photodynamic therapy chemoprevention in NBCCS do not exist. We herein report one patient treated with methyl aminolevulinate PDT with red light (630 nm) activation to continue sustained chemoprevention following other BCC chemopreventive modalities and a relevant literature review.
Asunto(s)
Síndrome del Nevo Basocelular/prevención & control , Carcinoma Basocelular/prevención & control , Neoplasias Faciales/prevención & control , Fotoquimioterapia , Neoplasias Cutáneas/prevención & control , Síndrome del Nevo Basocelular/patología , Carcinoma Basocelular/patología , Neoplasias Faciales/patología , Femenino , Humanos , Persona de Mediana Edad , Neoplasias Cutáneas/patologíaRESUMEN
Methyl aminolevulinate photodynamic therapy (MAL-PDT) is utilized in several countries for the treatment of basal cell carcinoma, but allergic sensitization has been reported by the manufacturer. To the best of our knowledge, we report the first case of urticaria following MAL-PDT in a patient with nevoid basal cell carcinoma syndrome. Prophylactic use of antihistamines may allow continued use of MAL-PDT in this setting.
Asunto(s)
Ácido Aminolevulínico/análogos & derivados , Fotoquimioterapia/efectos adversos , Fármacos Fotosensibilizantes/efectos adversos , Urticaria/etiología , Ácido Aminolevulínico/efectos adversos , Ácido Aminolevulínico/uso terapéutico , Síndrome del Nevo Basocelular/tratamiento farmacológico , Síndrome del Nevo Basocelular/patología , Carcinoma Basocelular/tratamiento farmacológico , Carcinoma Basocelular/patología , Femenino , Humanos , Persona de Mediana Edad , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/uso terapéutico , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/patologíaRESUMEN
Electron beam radiation is a commonly used and effective treatment modality for cutaneous malignancies. Secondary cutaneous malignancies arising in electron beam treatment sites are rarely reported. We report on seven patients who developed multiple secondary tumours arising within and immediately around electron beam radiation treatment sites in the setting of treatment for diffuse primary disease or as adjunctive therapy for aggressive cutaneous malignancies.
Asunto(s)
Carcinoma de Células Escamosas/etiología , Neoplasias de Cabeza y Cuello/etiología , Neoplasias Inducidas por Radiación/etiología , Neoplasias Primarias Secundarias/etiología , Cuero Cabelludo/patología , Neoplasias Cutáneas/etiología , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/radioterapia , Carcinoma de Células Escamosas/cirugía , Neoplasias de Cabeza y Cuello/radioterapia , Neoplasias de Cabeza y Cuello/cirugía , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Inducidas por Radiación/cirugía , Neoplasias Cutáneas/radioterapia , Neoplasias Cutáneas/cirugíaRESUMEN
We describe a rare case of atypical pyoderma gangrenosum of the dorsal hand in a patient who presented with the histopathologic diagnosis of squamous cell carcinoma (SCC). Atypical pyoderma gangrenosum is a rare variant of pyoderma gangrenosum that occurs on the upper extremities, presenting as a cutaneous ulcer. The correct treatment is nonsurgical, and surgical intervention often results in trauma-induced expansion of lesions. Pyoderma gangrenosum, most commonly mistaken for infection, has resulted in amputation. Histologic and clinical presentation 1 month after onset of symptoms in the patient reported here mimicked SCC. Awareness by hand surgeons of the possible histologic misdiagnosis of SCC at an early stage in the disease evolution and a high index of suspicion in the face of biopsy-proven SCC may prevent unnecessary digit amputation.